JUUL to Pay $462M to Resolve Vaping Nicotine Addiction Lawsuits Filed by Six States
New York, California and several other states have reached a $462 million settlement agreement to resolve JUUL teen vaping addiction lawsuits.
Tag Archives: JUUL Recall
-
-
Judge Approves Settlement for JUUL Vaping Addiction Lawsuits
A federal judge has granted preliminary approval for a settlement to resolve all JUUL vaping addiction lawsuits.
-
Court Outlines Process for Settling JUUL Addiction Lawsuits, and Other Claims
A federal judge has detailed the process for JUUL addiction lawsuit settlement proceedings to resolve thousands of claims that the company sold products to teens which fostered a nicotine addiction…
-
JUUL Settlement Reached To Resolve Teen Vaping Lawsuits
JUUL has announced it has reached a global settlement to resolve teen vaping lawsuits filed in federal courts nationwide.
-
Facing Potential JUUL Lawsuit Payouts and Vape Pen Recall, Manufacturer Is Now Considering Chapter 11 Bankruptcy: Reports
JUUL is reportedly in preliminary discussions regarding a potential Chapter 11 bankruptcy filing in the face of potentially costly nicotine addiction lawsuit payouts and an FDA ban.
-
JUUL Settlement Agreement Over Underage Marketing of Vape Pen Results in $440M Payment
JUUL has agreed to pay 34 states and territories a total of nearly $440 million to resolve claims it targeted underage customers with its marketing ploys.
-
FDA Agrees to Delay JUUL Market Removal to Give Manufacturer Time to Appeal
The FDA has agreed to place its own stay on a JUUL market removal order to give the manufacturer time to appeal the decision and address scientific questions about the…
-
JUUL Ban Delayed After Court Grants Temporary Stay Against FDA Order
The JUUL ban announced by the FDA last week has been temporarily put on hold while the manufacturer prepares an appeal, and possibly a bankruptcy filing as well.
-
JUUL Recall Coming in 2022 After FDA Decision to Ban Vaping Products from the U.S. Market
The FDA has decided to remove all JUUL products from the market, saying the company failed to demonstrate how they would be marketed in a way to protect public health.
